1. Berd D, Mastrangelo MJ, Lattime E, Sato T, Maguire HC Jr (1996) Melanoma and vitiligo: immunology’s Grecian urn. Cancer Immunol Immunother 42:263–267
2. Barnhill RL, Mihm MC (1992) Histopathology of malignant melanoma and its precursor lesions. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S (eds) Cutaneous melanoma, 2nd edn. JB Lippincott, Oxford
3. Balch CM, Soong S, Shaw HM, Urist MM, McCarthy WH (1992) An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S (eds) cutaneous melanoma, 2nd edn. JB Lippincott, Oxford
4. Cook MG (1992) The significance of inflammation and regression in melanoma. Virchows Arch A Pathol Anat Histopathol 420:113–115
5. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964